Bristol’s 2025 Guidance Falls Short, But CEO Boerner Warned This Was Coming
$2bn In Cost Cuts Planned; Medicare Redesign Neutral
Boerner warned a year ago that BMS may see its revenue falter in the middle of this decade and the company’s 2025 guidance suggests that will happen this year after 2024 beat consensus.
